Doubling Scopolamine Patches for Motion Sickness
Doubling up on scopolamine patches is not recommended for motion sickness as it exceeds FDA-approved dosing and may increase the risk of adverse effects without clear evidence of additional benefit.
Standard Dosing and Administration
The FDA-approved dosing for scopolamine transdermal patches for motion sickness is:
- One patch (1.5 mg) applied to the hairless area behind one ear at least 4 hours before the antiemetic effect is required 1
- Each patch is designed to deliver approximately 1 mg of scopolamine over 3 days 1
- The FDA label explicitly states: "Only wear one transdermal system at any time" 1
Evidence for Double Dosing
While one small study (n=20) found that double-dose transdermal scopolamine increased plasma concentrations from 81 pg/ml to 127 pg/ml without significant increases in adverse effects 2, this research is limited by:
- Small sample size
- Short duration (24 hours)
- Young, healthy male subjects only (18-21 years)
- Not endorsed by FDA labeling or clinical guidelines
Potential Risks of Exceeding Recommended Dose
Doubling the dose may increase the risk of adverse effects:
- Neuropsychiatric effects: confusion, disorientation, memory impairment, hallucinations 1
- Acute angle closure glaucoma in susceptible individuals 1
- Anticholinergic side effects: dry mouth, blurred vision, drowsiness 3
- Increased risk of cognitive impairment, especially in elderly patients 1
Alternative Approaches for Inadequate Motion Sickness Control
If a single scopolamine patch is ineffective, consider these alternatives:
Ensure proper application:
- Apply to clean, dry, hairless area behind the ear
- Apply at least 4 hours before antiemetic effect is needed 1
Try alternative medications:
- Antihistamines (meclizine 12.5-25 mg TID, dimenhydrinate 25-50 mg TID) 4
- Combination therapy with different mechanism agents
Non-pharmacological approaches:
- Position yourself where motion is minimized (center of boat, front seat of car)
- Focus on the horizon
- Avoid reading or screens during travel
- Consider use of handheld fans directed at the face 4
Conclusion
While one small study suggests double-dosing might be safe in young healthy males, the FDA labeling explicitly instructs to use only one patch at a time. The potential risks of adverse effects outweigh the uncertain benefits of doubling the dose. If motion sickness persists despite proper application of a single patch, consider alternative or complementary therapies rather than exceeding the recommended dose.